The pharmaceutical and life sciences industry is undergoing a tectonic shift, moving from static digital transformation to...
Chemotherapy and Targeted Therapy
For millions of individuals living with actinic keratoses (AK)—the rough, scaly, and potentially pre-cancerous patches of skin...
Rescuing Innovation: How the Children’s Tumor Foundation is Unlocking Shelved Rare Disease Therapies
Rescuing Innovation: How the Children’s Tumor Foundation is Unlocking Shelved Rare Disease Therapies
In the high-stakes world of pharmaceutical development, the journey from laboratory bench to patient bedside is often...
The long-held promise of the digital health revolution—that smartphones would one day act as medical instruments as...
The American biotechnology sector, long considered the undisputed global leader in pharmaceutical innovation, finds itself at a...
For decades, the medical community viewed metabolic dysfunction-associated steatohepatitis (MASH)—formerly known as NASH—as a clinical "graveyard." Despite...
Sixty years after Calvin Stevens first synthesized ketamine at Parke-Davis in a pursuit of safer anesthesia, the...
For decades, the KRAS gene—a critical regulator of cellular growth—was considered the "holy grail" of oncology and...
In the high-stakes world of biopharmaceutical manufacturing, the transition from clinical-stage promise to commercial-scale reality is often...
The biotechnology sector has seen a flurry of activity this week, characterized by bold government-led initiatives in...
